Relapsed acute lymphoblastic leukemia: back to the drawing board
1Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Hashomer Israel; Gray Faculty of Medical and Health Sciences, Aviv University, Aviv. elad.jacoby@sheba.health.gov.il.
Haematologica
|July 3, 2025
Summary
This study did not provide an abstract, so a summary cannot be generated. Further information is needed to create SEO-optimized content.
Area of Science:
- Not available.
Background:
- Not available.
Purpose of the Study:
- Not available.
Main Methods:
- Not available.
Main Results:
- Not available.
Conclusions:
- Not available.
Related Concept Videos
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:22Bone Marrow Sampling and Transplants
506
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
506